Allergan plc. (NYSE:AGN) has tumbled 2.44% during the past week, however, the bigger picture is still very bullish; the stocks have advanced and posted positive gains of 2.42% in the last four weeks. The stocks have underperformed the S&P 500 by 1.27% during the past week but Allergan plc. (NYSE:AGN) it has outperformed the index in 4 weeks by 1.49%.
Allergan plc. (NYSE:AGN): The stock opened at $237.64 on Friday but the bulls could not build on the opening and the stock topped out at $237.64 for the day. The stock traded down to $234.20 during the day, due to lack of any buying support eventually closed down at $235.05 with a loss of -0.94% for the day. The stock had closed at $237.29 on the previous day. The total traded volume was 3,284,170 shares.
On the companys insider trading activities, Hilado Maria Teresa, CFO of Allergan Plc, had purchased 661 shares on June 2, 2016. The total value of the transaction was $159,678. The information was disclosed with the SEC in a Form 4 Filing. The information is based on open market trades at the market prices.Option exercises are not covered.
Many analysts have stated their opinion on the company shares. Major Brokerage house, Piper Jaffray downgrades its ratings on Allergan plc. (NYSE:AGN). In the latest research report, Piper Jaffray lowers the target price from $311 per share to $238 per share. According to the latest information available, the shares are now rated Neutral by the analysts at the agency. Previously, the analysts had a Overweight rating on the shares. The rating by the firm was issued on April 18, 2016. Currently the company Insiders own 0.27% of Allergan plc. shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by 5.85% . Institutional Investors own 86.78% of Allergan plc. shares. During last six month period, the net percent change held by insiders has seen a change of 5.85%.